International Narcotics Control Board
| International Narcotics Control Board | |
|---|---|
| [[File:|250px|alt=]] | |
| Formation | 1968 |
| Type | Quasi-judicial control organ |
| Headquarters | Vienna, Austria |
| Membership | N/A |
| Language | N/A |
| Leader title | President |
| Leader name | [Information on current president] |
| Website | [No external links] |
The International Narcotics Control Board (INCB) is an independent, quasi-judicial expert body established by the Single Convention on Narcotic Drugs of 1961. The board is mandated to monitor and support governments in the implementation of the United Nations drug control conventions, and to ensure that adequate supplies of narcotic drugs and psychotropic substances are available for medical and scientific purposes, while preventing their diversion into illicit channels.
History
The INCB was established in 1968, pursuant to the 1961 Single Convention on Narcotic Drugs. It was created to succeed and expand upon the functions of the Permanent Central Opium Board and the Drug Supervisory Body, which were pre-existing bodies under earlier international drug control treaties.
Functions
The primary functions of the INCB include:
- Monitoring the implementation of the United Nations drug control conventions
- Ensuring that governments adhere to the limits of narcotic drug and psychotropic substance production, established to meet medical and scientific needs
- Providing assistance to governments to help them meet their treaty obligations
- Working to prevent the diversion of drugs from legal to illicit channels
The INCB also publishes an annual report that provides a comprehensive overview of the drug control situation in various countries, highlighting existing challenges and making recommendations to improve the effectiveness of the international drug control system.
Structure
The INCB consists of thirteen members who are elected by the Economic and Social Council of the United Nations from a list of candidates nominated by Governments. These members serve in their personal capacities and are expected to bring a wide range of expertise in drug-related matters.
Criticism and Controversies
The INCB has faced criticism for its conservative stance on drug control policies, particularly regarding its approach to new developments such as the legalization of cannabis for recreational and medicinal purposes in some countries. Critics argue that the INCB's positions sometimes lack flexibility and may hinder the adoption of progressive drug policies that could lead to better health and social outcomes.
See also
International_Narcotics_Control_Board
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD